Dolutegravir Price likely to face an Increase in March 2025 Following February Price Drop

Dolutegravir, an essential antiretroviral medication primarily used in the treatment of HIV-1 infection, is expected to experience a slight price increase in India in March 2025. This follows a significant price drop in February this year.

Key Takeaways

• Dolutegravir prices in India are predicted to rise in...
  Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

  LOGIN TO VIEW THE FULL NEWS

  Tags:

  Dolutegravir Prices

  Demand and Supply